ClinicalTrialsFinder

HER-2 ADC Clinical Trials in Shanghai, Shanghai Municipality

1 recruitingShanghai, Shanghai Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients

Upper Urinary Tract Urothelial CarcinomaKidney PreservationHER-2 ADC+1 more
RenJi Hospital20 enrolled1 locationNCT05912816